The Injective community has okayed a governance proposal that shifts INJ into a more aggressive deflationary phase. A governance proposal that lowers the INJ token’s long-term supply and modifies the ...

Approved with 99.89% support, the proposal updates issuance and buyback parameters that govern how INJ is removed from circulation over time. Injective’s protocol community approved a major tokenomics ...

Injective, a high-performance blockchain designed for finance-focused decentralized applications, today launched its dedicated research page. The new hub provides centralized access to technical ...

Four and a half years ago, Eric Chen and Albert Chon, the founders of financial blockchain company Injective, achieved a feat many entrepreneurs only dream of: They landed Mark Cuban as an investor.

From electronic health records and blood tests to the stream of data from wearable devices, the amount of health information people generate is accelerating rapidly. Yet, many users struggle to ...

The cryptocurrency market remained weak on Wednesday, as Bitcoin continued to struggle around $90,000. Altcoins display mixed performances after the latest crash violated key price levels. This ...

It seems to me that there are big issues with the invert function in the homomorphisms file in the combinatorics section. The function is supposed to do this: Return an element of the preimage of ...

Layer-1 blockchain Injective has rolled out what it calls its most significant upgrade yet: a native Ethereum Virtual Machine (EVM) layer. The upgrade aims to make Injective a go-to platform for ...

Injective, the blockchain built for finance, has launched iBuild, a Web3 platform that enables anyone to build and deploy blockchain applications without writing code. Powered by Injective’s MultiVM ...

The L1 project burns over 6.7M tokens in its first community buyback. The initiative aims to reward active network participants. Another buyback is slated for November, strengthening Injective’s ...

21Shares has filed for a new spot Injective (INJ) ETF with the US Securities and Exchange Commission. The ETF issuer submitted the application on October 20, 2025, making Injective one of the altcoins ...